Patents by Inventor Michael Brenner Weiss

Michael Brenner Weiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20220071896
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Inventors: Fintan KEEGAN, Robert Gerard BELL, Roger CRYSTAL, Michael Brenner WEISS
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20210275519
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: December 18, 2020
    Publication date: September 9, 2021
    Inventors: Roger CRYSTAL, Michael Brenner WEISS
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20210093557
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: May 7, 2020
    Publication date: April 1, 2021
    Inventors: Fintan KEEGAN, Robert Gerard BELL, Roger CRYSTAL, Michael Brenner WEISS
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20200030229
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: October 8, 2019
    Publication date: January 30, 2020
    Inventors: Fintan KEEGAN, Robert Gerard BELL, Roger CRYSTAL, Michael Brenner WEISS
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20190015323
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: September 14, 2018
    Publication date: January 17, 2019
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 10085937
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: October 2, 2018
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • CO-PACKAGED DRUG PRODUCTS
    Publication number: 20180169006
    Abstract: Provided herein are drug products comprising a combination of an opioid receptor agonist and an opioid receptor agonists, including co-packaged drug products comprising an opioid receptor agonist and an opioid receptor antagonist in a delivery device selected from a hand-held auto-injector and a pre-primed nasal delivery device, and methods of prescribing and dispensing same. Methods of lowering opioid overdose risk by providing a combination of an opioid receptor agonist and an opioid receptor agonists, for example by co-packaging an opioid receptor agonist and an opioid receptor antagonist in a delivery device, are also provided.
    Type: Application
    Filed: July 26, 2017
    Publication date: June 21, 2018
    Inventors: Roger CRYSTAL, Michael Brenner WEISS
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170304295
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: April 21, 2017
    Publication date: October 26, 2017
    Inventors: Roger CRYSTAL, Michael Brenner WEISS
  • Nasal drug products and methods of their use
    Patent number: 9775838
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: October 3, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170239241
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: May 8, 2017
    Publication date: August 24, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9707226
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: July 18, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170151231
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170151230
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: January 25, 2017
    Publication date: June 1, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9629965
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: April 25, 2017
    Assignee: Opiant Pharmaceuticals, Inc.
    Inventors: Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170071851
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: September 16, 2016
    Publication date: March 16, 2017
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20170043107
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Inventors: Roger CRYSTAL, Michael Brenner WEISS
  • Nasal drug products and methods of their use
    Patent number: 9561177
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: February 7, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9480644
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: November 16, 2015
    Date of Patent: November 1, 2016
    Assignee: Opiant Pharmaceuticals, Inc.
    Inventors: Roger Crystal, Michael Brenner Weiss
  • NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
    Publication number: 20160303041
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Application
    Filed: June 15, 2016
    Publication date: October 20, 2016
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9468747
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: October 18, 2016
    Assignee: Opiant Pharmaceuticals, Inc.
    Inventors: Roger Crystal, Michael Brenner Weiss